The time is now to align on a shared plan of action as a country to achieve diversity, equity, inclusion, and access in US ...
Real progress in health inequities requires meeting communities where they are and addressing the root causes of medical ...
This study has shown clinical proof of concept, particularly in treating aggressive SMARCA4-mutated cancers such as non-small ...
In clinical nutrition, as in other areas of veterinary medicine, the patient approach encompasses not only animal-related ...
Jazmin Evans was diagnosed with kidney disease at the age of 17 in 2012. She received a kidney transplant in July 2023, after ...
Novo Nordisk has reported positive outcomes from part one of the ESSENCE trial of semaglutide 2.4 mg in treating MASH and ...
The report is another blow to digital health companies that are attempting to gain traction in a crowded market.
Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus to the ...
Pliant Therapeutics (PLRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed ...
Sanofi is conducting the two-part multicenter, randomized, open-label, controlled, parallel-group study (NCT04643002) to evaluate the safety, efficacy, pharmacokinetics and biomarker data of ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...
Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple clinical data reports planned for 2025 -- -- Enrolling patients with LBCL (2L and after prior CD19 ...